| Subject: | FDA Issues Public Health Advisory for Dolophine (Methadone Hydrochloride); FDA Recalls 18 Lots of Complete ® MoisturePLUS Multipurpose Contact Lens Care Solution and Active Packs |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Thu, 30 Nov 2006 - 12:00 am |
| The FDA has notified healthcare professionals of reports of death and life-threatening adverse events such as respiratory depression and cardiac arrhythmias in patients receiving methadone. These adverse events are the possible result of unintentional methadone overdoses, drug interactions, and methadone's cardiac toxicities (QT prolongation and Torsades de Pointes).
According to the FDA, physicians prescribing methadone should be familiar with methadone’s toxicities and unique pharmacologic... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
REFERENCES:
Policies / Forms / Additional Resources:
External Links:
|
|
StayAlert!® Virtual Compliance Administrator™ keeps clients informed by email of any changes to Federal regulations, including Joint Commission (TJC, formerly JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG, and many more, and also provides downloadable tools to ensure compliance. StayAlert! is a premium product sold as an annual site-license subscription. With the site license, the client can sign up an unlimited number of users for the email alerts and access to the StayAlert! online regulatory library. Currently StayAlert! is the leader in the comprehensive compliance information marketplace. Why? Because StayAlert! provides healthcare professionals with more than information. StayAlert! provides a service, in many cases "doing the work" for you, and assisting regulatory compliance officers to effectively and efficiently meet changing standards. |
|
